CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,493,776 | -18.1% | 3,251,954 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $109,322,018 | -6.5% | 3,221,987 | -0.9% | 0.00% | 0.0% |
| Q1 2023 | $116,957,955 | -18.6% | 3,250,638 | +0.8% | 0.00% | -40.0% |
| Q4 2022 | $143,725,593 | +63.3% | 3,224,716 | +3.0% | 0.01% | +66.7% |
| Q3 2022 | $87,995,000 | +3.6% | 3,130,413 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $84,962,000 | -18.1% | 3,151,469 | +3.4% | 0.00% | 0.0% |
| Q1 2022 | $103,773,000 | -13.4% | 3,046,822 | -1.7% | 0.00% | 0.0% |
| Q4 2021 | $119,823,000 | -29.2% | 3,101,030 | -1.0% | 0.00% | -40.0% |
| Q3 2021 | $169,191,000 | +87.3% | 3,133,770 | +16.0% | 0.01% | +66.7% |
| Q2 2021 | $90,310,000 | +353.0% | 2,700,650 | +179.0% | 0.00% | +200.0% |
| Q1 2021 | $19,938,000 | +32.1% | 967,873 | +12.4% | 0.00% | – |
| Q4 2020 | $15,092,000 | +28.6% | 861,381 | +8.8% | 0.00% | – |
| Q3 2020 | $11,739,000 | +118.9% | 791,596 | +91.9% | 0.00% | – |
| Q2 2020 | $5,362,000 | +837.4% | 412,452 | +19.7% | 0.00% | – |
| Q1 2020 | $572,000 | -25.0% | 344,483 | +0.7% | 0.00% | – |
| Q4 2019 | $763,000 | +4.7% | 342,219 | -0.1% | 0.00% | – |
| Q3 2019 | $729,000 | -20.2% | 342,492 | +0.5% | 0.00% | – |
| Q2 2019 | $914,000 | -38.7% | 340,938 | +12.5% | 0.00% | – |
| Q1 2019 | $1,491,000 | – | 303,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |